Crohn's disease for the general physician: management
1Gastroenterology Specialist Trainee, Department of Gastroenterology, University Hospital of Wales, Cardiff.
British Journal of Hospital Medicine (London, England : 2005)
|February 7, 2017
Summary
This article details managing Crohn's disease, focusing on patient monitoring and potential drug toxicity. It provides essential information for physicians treating this complex gastrointestinal condition.
Area of Science:
- Gastroenterology
- Internal Medicine
- Clinical Practice
Background:
- Crohn's disease exhibits diverse clinical presentations.
- Effective management requires understanding of various therapeutic strategies.
- Monitoring and managing drug toxicity are crucial for patient outcomes.
Purpose of the Study:
- To outline the management of Crohn's disease.
- To detail patient monitoring protocols.
- To address drug toxicity in Crohn's disease treatment.
Main Methods:
- Review of current clinical guidelines for Crohn's disease management.
- Analysis of data on monitoring strategies and adverse drug events.
- Synthesis of evidence regarding therapeutic interventions.
Main Results:
- Comprehensive overview of Crohn's disease management approaches.
- Identification of key parameters for patient monitoring.
- Discussion of common and serious drug toxicities associated with Crohn's disease therapies.
Conclusions:
- Effective Crohn's disease management involves vigilant monitoring and proactive management of drug toxicity.
- Physicians require up-to-date knowledge on treatment strategies and potential complications.
- Optimizing patient care necessitates a thorough understanding of both disease progression and therapeutic side effects.
Related Concept Videos
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
990
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
990
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
618
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
618
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
588
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
588
01:29Inflammatory Bowel Disease IV: Pharmacological Management
875
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
875
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
01:21Inflammatory Bowel Disease V: Surgical Management
789
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
789